Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Real-World Effectiveness of Voxelotor for Treating Sickle Cell Disease in the US

Ahmar Urooj Zaidi, MD, Thokozeni Lipato, MD, Ofelia A. Alvarez, MD, Alexander Lonshteyn, PhD, Derek Weycker, PhD, Nhat Pham, Thomas E Delea, MSIA, Irene Agodoa, MD, Ze Cong, PhD, Nirmish Shah, MD

Blood (2020) 136 (Supplement 1): 25.

https://doi.org/10.1182/blood-2020-140525

Published: 2020

Journal Articles

Development of a Low-Cost Electrical Impedance-Based Microflow Cytometer

Darryl Dieujuste, BS,MS, Jia Liu, E. Du, PhD, Ofelia A. Alvarez, MD

Blood (2019) 134 (Supplement_1): 4665.

https://doi.org/10.1182/blood-2019-129068

Published: 2019

Journal Articles

Patient Perception on Health Care Delivery for Sickle Cell Disease and Opportunities for Quality Improvement

Ofelia A. Alvarez, MD, Sandra Echenique, Hector Rodriguez-Cortes, MD, Thomas J. Harrington, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Vandy Black, MDMSc, Mary Murph, Christopher Wells, Ifeyinwa (ify) Osunkwo, MDMPH

Blood (2019) 134 (Supplement_1): 5862.

https://doi.org/10.1182/blood-2019-123215

Published: 2019

Journal Articles

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Nora St Victor Dély, MD, Ofelia A. Alvarez, MD, Vanessa J Dor, MD, Emmeline Lerebours, MD

Blood (2019) 134 (Supplement_1): 2306.

https://doi.org/10.1182/blood-2019-124105

Published: 2019

Journal Articles

Role of Point-of-Care Device in Improving Sickle Cell Newborn Screening Feasibility in Haiti

Ofelia A. Alvarez, MD, Tally Hustace, ARNP, Mimose Voltaire, RN, Rodrigueson Rizil, Ulrick Liberus, Rony Saint Fleur, MD

Blood (2018) 132 (Supplement 1): 3670.

https://doi.org/10.1182/blood-2018-99-115384

Published: 2018

Journal Articles

Optimal Hemoglobin Level for Pediatric Sickle Cell Patients Who Undergo Adenotonsillectomy

Zhongbo Hu, MD PhD, Simone Megan Chang, MD, Ramzi Younis, MD, Ofelia A. Alvarez, MD

Blood (2018) 132 (Supplement 1): 4938.

https://doi.org/10.1182/blood-2018-99-119452

Published: 2018

Journal Articles

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Kenneth I. Ataga, MD, Abdullah Kutlar, MD, Julie Kanter, MD, Darla Liles, MD, Rodolfo Cancado, MD, PhD, João Friedrisch, MD PhD, Troy H. Guthrie, MD, Jennifer Knight-Madden, MBBS, PhD, Ofelia A. Alvarez, MD, Victor R. Gordeuk, MD, Sandra Gualandro, MD PhD, Marina Pereira Collela, MD PhD, Wally R. Smith, MD, Scott A. Rollins, PhD, Jonathan W. Stocker, PhD, Russell P. Rother, PhD

Blood (2016) 128 (22): 1.

https://doi.org/10.1182/blood.V128.22.1.1

Published: 2016

Journal Articles

Genetic Modifiers Influencing the Development of Albuminuria in Children with Sickle Cell Anemia

Beverly A Schaefer, MD, Jonathan M Flanagan, PhD, Banu Aygun, MD, Ofelia A. Alvarez, MD, Stephen C Nelson, MD, Kerri A Nottage, MD MPH, Carla W Roberts, MD, Thad A. Howard, MS, Barry R Davis, MDPhD, Russell E. Ware, MD PhD

Blood (2015) 126 (23): 3393.

https://doi.org/10.1182/blood.V126.23.3393.3393

Published: 2015

Journal Articles

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Russell E. Ware, MD PhD, Barry R Davis, MD PhD, William H Schultz, MHS PA, Clark Brown, MD PhD, Banu Aygun, MD, Sharada A. Sarnaik, MD, Isaac Odame, MD, Beng Fuh, MD, Alex George, MD, PhD, William Owen, MD, Lori Luchtman-Jones, MD, Zora R. Rogers, MD, Lee Hilliard, MD, Cynthia Gauger, MD, Connie M. Piccone, MD, Margaret T. Lee, MD, Janet Kwiatkowski, MD, Sherron Jackson, MD, Scott T. Miller, MD, Carla W Roberts, MD, Matthew M. Heeney, MD FRCP(C), Theodosia A. Kalfa, MD PhD, Stephen C Nelson, MD, Hamayun Imran, MD, Kerri A Nottage, MD MPH, Ofelia A. Alvarez, MD, Melissa Rhodes, MD, Alexis A. Thompson, MD, Jennifer Rothman, MD, Kathleen J. Helton, MD, Donna Roberts, MD, Jamie Coleman, MD, Melanie J Bonner, PhD, Abdullah Kutlar, MD, Niren Patel, MD, John C Wood, MD PhD, Linda Piller, MD, Peng Wei, PhD, Judy Luden, CCRP, Nicole A. Mortier, MHS, PA-C, Susan Stuber, MA, Naomi L.C. Luban, MD, Alan R. Cohen, MD, Sara L Pressel, MS, Robert J. Adams, MD MS

Blood (2015) 126 (23): 3.

https://doi.org/10.1182/blood.V126.23.3.3

Published: 2015

Journal Articles

An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia

Timothy L. McCavit, MD, MS, Lakshmanan Krishnamurti, MD, Lewis L. Hsu, MD, PhD, Charles T. Quinn, MD, MS, Isaac Odame, MD, Ofelia A. Alvarez, MD, Catherine Driscoll, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Ted Wun, MD, Marilyn J. Telen, MD, Helen Thackray, MD

Blood (2013) 122 (21): 2206.

https://doi.org/10.1182/blood.V122.21.2206.2206

Published: 2013

Journal Articles

Does Vitamin D Deficiency Play a Role in Sickle Cell Nephropathy?

Dima A Hamideh, MD, Vimal Raj, MD, Gaston Zilleruelo, MD, Ofelia A. Alvarez, MD

Blood (2012) 120 (21): 4755.

https://doi.org/10.1182/blood.V120.21.4755.4755

Published: 2012

Journal Articles

A Randomized, Open-Label, Multicenter, Dose Escalation Study of HQK-1001 (2,2-Dimethylbutyrate, Sodium Salt) in Sickle Cell Disease

Abdullah Kutlar, MD, Marvin Reid, PhD, Ali T Taher, MD, Adlette Inati, MD, Miguel R. Abboud, MD, Amal El-Beshlawy, MD, George R. Buchanan, MD, Hedy Smith, MD PhD, Kenneth I. Ataga, MD, Nebu Koshy, MD, FACP, Lynne D Neumayr, MD, Punam Malik, M.D., Ofelia A. Alvarez, MD, Richard Ward, MBBS, MRCP, FRCPath, J Michael White, PhD, Elsa Johnson, MBA, Richard G. Ghalie, MD

Blood (2012) 120 (21): 998.

https://doi.org/10.1182/blood.V120.21.998.998

Published: 2012

Journal Articles

Therapeutic Phlebotomy in Children with Sickle Cell Anemia, Stroke, and Iron Overload: The SWiTCH Experience

Banu Aygun, MD, Nicole A Mortier, PA-C, Karen Kesler, PhD, Willliam H Schultz, PA-C, Ofelia A. Alvarez, MD, Zora R. Rogers, MD, Janet L. Kwiatkowski, MD, MSCE, Scott T Miller, MD, Pamela Sylvestre, MD, Alan R. Cohen, MD, Russell E. Ware, MD, PhD

Blood (2011) 118 (21): 1044.

https://doi.org/10.1182/blood.V118.21.1044.1044

Published: 2011

Journal Articles

Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

Zora R. Rogers, MD, Billie Fish, CCRP, Zhaoyu Luo, PhD, Rathi V. Iyer, MD, Courtney D. Thornburg, MD, MS, Sharada A. Sarnaik, MD, Sohail R. Rana, MD, Lori Luchtman-Jones, MD, Sherron M. Jackson, MD, Thomas H. Howard, MD, James F. Casella, MD, R. Clark Brown, MD, PhD, Ofelia A. Alvarez, MD, Jonathan C. Goldsmith, MD, Scott T. Miller, MD, Winfred C. Wang, MD

Blood (2011) 118 (21): 7.

https://doi.org/10.1182/blood.V118.21.7.7

Published: 2011

Journal Articles

Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Russell E. Ware, MD, PhD, Renee C. Rees, PhD, Sharada A. Sarnaik, MD, Rathi V. Iyer, MD, Ofelia A. Alvarez, MD, James F. Casella, MD, Barry L. Shulkin, MD, Eglal Shalaby-Rana, MD, C. Frederic Strife, MD, John H. Miller, MD, Peter A. Lane, Jr., MD, Winfred C. Wang, Scott T. Miller, MD, The BABY HUG Investigators

Blood (2008) 112 (11): 1414.

https://doi.org/10.1182/blood.V112.11.1414.1414

Published: 2008

Journal Articles

Serum Cystatin-C Levels in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

Scott T. Miller, MD, Russell E. Ware, MD, PhD, Abdullah Kutlar, MD, Ofelia A. Alvarez, MD, Rathi V. Iyer, MD, Sharada A. Sarnaik, MD, Sohail R Rana, MD, Zora R. Rogers, MD, Peter A. Lane, Jr., MD, Renee C Rees, PhD, The BABY HUG Investigators

Blood (2008) 112 (11): 4791.

https://doi.org/10.1182/blood.V112.11.4791.4791

Published: 2008

Journal Articles

Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.

Tom Adamkiewicz, MD, Miguel R. Abboud, MD, Julio C. Barredo, MD, Melanie Kirby-Allen, MD, Ofelia A. Alvarez, MD, James F. Casella, MD, Rathi V. Iyer, MD, Virgil McKie, MD, Gerald Milton Woods, MD, Abdullah Kutlar, MD, Carole Paley, MD, Jessica Peterson, Elizabeth Rackoff, Manuela Merelles-Pulcini, Elizabeth Dackiw, Kristin Stegenga, Nadine Odo, Mimi Lou, Robert J. Adams, MD

Blood (2006) 108 (11): 791.

https://doi.org/10.1182/blood.V108.11.791.791

Published: 2006

Journal Articles

Serum Cystatin C Is a Better Marker for Renal Function Than Serum Creatinine in Children with Sickle Cell Disease.

Ofelia A. Alvarez, MD, Dale Wright, PA, Gabriela Lopez, MS, Gaston Zilleruelo, MD

Blood (2005) 106 (11): 3774.

https://doi.org/10.1182/blood.V106.11.3774.3774

Published: 2005

NARROW

Real-World Effectiveness of Voxelotor for Treating Sickle Cell Disease in the US

Development of a Low-Cost Electrical Impedance-Based Microflow Cytometer

Patient Perception on Health Care Delivery for Sickle Cell Disease and Opportunities for Quality Improvement

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Role of Point-of-Care Device in Improving Sickle Cell Newborn Screening Feasibility in Haiti

Optimal Hemoglobin Level for Pediatric Sickle Cell Patients Who Undergo Adenotonsillectomy

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Genetic Modifiers Influencing the Development of Albuminuria in Children with Sickle Cell Anemia

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia

Does Vitamin D Deficiency Play a Role in Sickle Cell Nephropathy?

A Randomized, Open-Label, Multicenter, Dose Escalation Study of HQK-1001 (2,2-Dimethylbutyrate, Sodium Salt) in Sickle Cell Disease

Therapeutic Phlebotomy in Children with Sickle Cell Anemia, Stroke, and Iron Overload: The SWiTCH Experience

Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Serum Cystatin-C Levels in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.

Serum Cystatin C Is a Better Marker for Renal Function Than Serum Creatinine in Children with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only